UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence and sociodemographic characteristics of US community-dwelling older adults with communication disabilities, using the national health and aging trends survey

Journal of communication disorders, 2023-03, Vol.102, p.106316-106316, Article 106316

2023

Volltextzugriff (PDF)

High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in a male patient with osteoporosis

Clinical interventions in aging, 2018-01, Vol.13, p.1929-1934

2018

Volltextzugriff (PDF)

Determinants of Bronchodilator Responsiveness in Patients with Controlled Asthma

The Journal of asthma, 2006, Vol.43 (1), p.71-74

2006

Volltextzugriff (PDF)

Enhancement of a Sense of Coherence and Natural Killer Cell Activity which Occurred in Subjects who Improved their Exercise Habits through Health Education in the Workplace

Journal of occupational health, 2003-09, Vol.45 (5), p.278-285

2003

Volltextzugriff (PDF)

Phase II Study of Irinotecan and Ifosfamide in Patients with Advanced Non-Small Cell Lung Cancer

Oncology, 2003-01, Vol.64 (4), p.306-311

2003

Volltextzugriff (PDF)

Efficacy and safety of auranofin in patients with active early rheumatoid arthritis

Clinical therapeutics, 1995, Vol.17 (1), p.60-73

1995

Volltextzugriff (PDF)

Bronchial amyloidosis successfully treated with low-dose long-term erythromycin therapy

Kurume medical journal, 1999, Vol.46 (3-4), p.185-189

1999

Volltextzugriff (PDF)

Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer

British journal of surgery, 2009-09, Vol.96 (9), p.1015-1022

2009

Volltextzugriff (PDF)

Radiographic and pathological analysis of small lung adenocarcinoma using the new IASLC classification

Clinical radiology, 2013-01, Vol.68 (1), p.e21-e26

2013

Volltextzugriff (PDF)

Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)

Journal of cancer research and clinical oncology, 2014-02, Vol.140 (2), p.319-328

2014

Volltextzugriff (PDF)

Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion

British journal of cancer, 2010-08, Vol.103 (4), p.517-523

2010

Volltextzugriff (PDF)

Initial findings and progression of lung adenocarcinoma on serial computed tomography scans

Journal of computer assisted tomography, 2009-01, Vol.33 (1), p.42-48

2009

Volltextzugriff (PDF)

Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin

Journal of viral hepatitis, 2009-08, Vol.16 (8), p.586-594

2009

Volltextzugriff (PDF)

A phase II trial of dose-dense chemotherapy, followed by surgical resection and or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)

British journal of cancer, 2010-06, Vol.103 (1), p.6-11

2010

Volltextzugriff (PDF)

Current State of Gastric Stump Carcinoma in Japan: Based on the Results of a Nationwide Survey

World journal of surgery, 2010-07, Vol.34 (7), p.1540-1547

2010

Volltextzugriff (PDF)

Novel heteroduplex method using small cytology specimens with a remarkably high success rate for analysing EGFR gene mutations with a significant correlation to gefitinib efficacy in non-small-cell lung cancer

British journal of cancer, 2006-10, Vol.95 (8), p.1070-1075

2006

Volltextzugriff (PDF)

The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

Journal of viral hepatitis, 2015-03, Vol.22 (3), p.254-262

2015

Volltextzugriff (PDF)

Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin

Journal of viral hepatitis, 2014-05, Vol.21 (5), p.357-365

2014

Volltextzugriff (PDF)

Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809

British journal of cancer, 2013-08, Vol.109 (3), p.545-551

2013

Volltextzugriff (PDF)

Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non‐small cell lung cancer

Cancer science, 2004-08, Vol.95 (8), p.691-695

2004

Volltextzugriff (PDF)

Phase II study of nedaplatin and irinotecan with concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer

British journal of cancer, 2010-10, Vol.103 (9), p.1325-1330

2010

Volltextzugriff (PDF)

A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)

British journal of cancer, 2009-02, Vol.100 (3), p.464-469

2009

Volltextzugriff (PDF)

HER2 expression in locally advanced gastric cancer with extensive lymph node (bulky N2 or paraaortic) metastasis (JCOG1005-A trial)

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2015-07, Vol.18 (3), p.467-475

2015

Volltextzugriff (PDF)

Using recipient's middle hepatic vein for drainage of the right paramedian sector in right liver graft

Transplantation, 2008-12, Vol.86 (11), p.1565-1571

2008

Volltextzugriff (PDF)

Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses

Journal of viral hepatitis, 2010-05, Vol.17 (5), p.336-344

2010

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(82)

Sprache

Englisch
(74)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Humans
(82)
Middle Aged
(76)
Male
(75)
Female
(71)
Life Sciences & Biomedicine
(66)
Science & Technology
(66)
Adult
(63)
Biological And Medical Sciences
(40)
Medical Sciences
(40)
Oncology
(39)
Lung Neoplasms - Drug Therapy
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Chemotherapy
(23)
Lung Neoplasms - Pathology
(23)
Aged, 80 And Over
(21)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(19)
Pharmacology. Drug Treatments
(18)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(16)
Treatment Outcome
(16)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence and sociodemographic characteristics of US community-dwelling older adults with communication disabilities, using the national health and aging trends survey

High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in a male patient with osteoporosis

Determinants of Bronchodilator Responsiveness in Patients with Controlled Asthma

Enhancement of a Sense of Coherence and Natural Killer Cell Activity which Occurred in Subjects who Improved their Exercise Habits through Health Education in the Workplace

Phase II Study of Irinotecan and Ifosfamide in Patients with Advanced Non-Small Cell Lung Cancer

Efficacy and safety of auranofin in patients with active early rheumatoid arthritis

Bronchial amyloidosis successfully treated with low-dose long-term erythromycin therapy

Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer

Radiographic and pathological analysis of small lung adenocarcinoma using the new IASLC classification

Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)

Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion

Initial findings and progression of lung adenocarcinoma on serial computed tomography scans

Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin

A phase II trial of dose-dense chemotherapy, followed by surgical resection and or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)

Current State of Gastric Stump Carcinoma in Japan: Based on the Results of a Nationwide Survey

Novel heteroduplex method using small cytology specimens with a remarkably high success rate for analysing EGFR gene mutations with a significant correlation to gefitinib efficacy in non-small-cell lung cancer

The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin

Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809

Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non‐small cell lung cancer

Phase II study of nedaplatin and irinotecan with concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer

A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)

HER2 expression in locally advanced gastric cancer with extensive lymph node (bulky N2 or paraaortic) metastasis (JCOG1005-A trial)

Using recipient's middle hepatic vein for drainage of the right paramedian sector in right liver graft

Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses

Aktive Filter

Suchergebnisse filtern